These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 35442226)

  • 21. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.
    Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C
    J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
    Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
    Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease.
    Skovbjerg H; Norén O; Anthonsen D; Moller J; Sjöström H
    Scand J Gastroenterol; 2002 Jul; 37(7):812-7. PubMed ID: 12190095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
    Rauhavirta T; Hietikko M; Salmi T; Lindfors K
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent.
    Biagi F; Campanella J; Laforenza U; Gastaldi G; Tritto S; Grazioli M; Villanacci V; Corazza GR
    Dig Liver Dis; 2006 Sep; 38(9):652-8. PubMed ID: 16916632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathogenesis of coeliac disease.
    Dewar D; Pereira SP; Ciclitira PJ
    Int J Biochem Cell Biol; 2004 Jan; 36(1):17-24. PubMed ID: 14592529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological effects of transglutaminase-treated gluten in coeliac disease.
    Elli L; Roncoroni L; Hils M; Pasternack R; Barisani D; Terrani C; Vaira V; Ferrero S; Bardella MT
    Hum Immunol; 2012 Oct; 73(10):992-7. PubMed ID: 22836039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A radioimmunoassay for wheat gliadin to assess the suitability of gluten free foods for patients with coeliac disease.
    Ciclitira PJ; Ellis HJ; Evans DJ; Lennox ES
    Clin Exp Immunol; 1985 Mar; 59(3):703-8. PubMed ID: 3987095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease.
    Leffler D; Schuppan D; Pallav K; Najarian R; Goldsmith JD; Hansen J; Kabbani T; Dennis M; Kelly CP
    Gut; 2013 Jul; 62(7):996-1004. PubMed ID: 22619366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ages of celiac disease: from changing environment to improved diagnostics.
    Tommasini A; Not T; Ventura A
    World J Gastroenterol; 2011 Aug; 17(32):3665-71. PubMed ID: 21990947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis.
    Lerner A; Matthias T
    Nutr Rev; 2015 Aug; 73(8):544-52. PubMed ID: 26084478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of transglutaminase and sourdough on gluten-free flours to improve dough structure.
    Scarnato L; Serrazanetti DI; Aloisi I; Montanari C; Del Duca S; Lanciotti R
    Amino Acids; 2016 Oct; 48(10):2453-65. PubMed ID: 27188419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.
    Ankelo M; Kleimola V; Simell S; Simell O; Knip M; Jokisalo E; Tarkia M; Westerlund A; He Q; Viander M; Ilonen J; Hinkkanen AE
    Clin Exp Immunol; 2007 Nov; 150(2):285-93. PubMed ID: 17803713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial transglutaminase treatment in pasta-production does not affect the immunoreactivity of gliadin with celiac disease patients' sera.
    Ruh T; Ohsam J; Pasternack R; Yokoyama K; Kumazawa Y; Hils M
    J Agric Food Chem; 2014 Jul; 62(30):7604-11. PubMed ID: 24998318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides.
    Lexhaller B; Ludwig C; Scherf KA
    Sci Rep; 2020 May; 10(1):7426. PubMed ID: 32367038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial transglutaminase should be considered as an environmental inducer of celiac disease.
    Lerner A; Matthias T
    World J Clin Cases; 2019 Nov; 7(22):3912-3914. PubMed ID: 31799322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease.
    Kaukinen K; Sulkanen S; Mäki M; Collin P
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):311-5. PubMed ID: 11953698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbial transglutaminase: A new potential player in celiac disease.
    Aaron L; Torsten M
    Clin Immunol; 2019 Feb; 199():37-43. PubMed ID: 30543926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No induction of anti-avenin IgA by oats in adult, diet-treated coeliac disease.
    Guttormsen V; Løvik A; Bye A; Bratlie J; Mørkrid L; Lundin KE
    Scand J Gastroenterol; 2008; 43(2):161-5. PubMed ID: 18224563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.